Overview

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

Status:
Completed

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

Multicentre, Double blind, Randomized, Comparative Study(comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device. Evaluation of the effects and safety of NAABAK® through inflammation markers and symptoms in patients with allergic conjunctivitis and dry eye syndrome after 3 months treatment. The patients will attend 4 visits.

Phase:

Phase 4

Details

Lead Sponsor:

Laboratoires Thea

Collaborator:

Samil Pharmaceutical Co., Ltd.

Treatments:

Ophthalmic Solutions
Tetrahydrozoline